Free Trial

Hussman Strategic Advisors Inc. Takes Position in Pediatrix Medical Group, Inc. (NYSE:MD)

Pediatrix Medical Group logo with Medical background

Hussman Strategic Advisors Inc. purchased a new stake in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 84,000 shares of the company's stock, valued at approximately $1,217,000. Hussman Strategic Advisors Inc. owned approximately 0.10% of Pediatrix Medical Group as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in MD. Nomura Asset Management Co. Ltd. boosted its holdings in Pediatrix Medical Group by 95.3% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock valued at $33,000 after acquiring an additional 1,220 shares during the last quarter. GAMMA Investing LLC lifted its position in Pediatrix Medical Group by 219.5% during the 1st quarter. GAMMA Investing LLC now owns 2,569 shares of the company's stock worth $37,000 after buying an additional 1,765 shares in the last quarter. Tower Research Capital LLC TRC increased its position in shares of Pediatrix Medical Group by 218.0% during the 4th quarter. Tower Research Capital LLC TRC now owns 7,445 shares of the company's stock worth $98,000 after purchasing an additional 5,104 shares during the last quarter. Squarepoint Ops LLC bought a new stake in shares of Pediatrix Medical Group in the 4th quarter valued at about $132,000. Finally, Sherbrooke Park Advisers LLC acquired a new stake in Pediatrix Medical Group during the 4th quarter valued at $136,000. Institutional investors and hedge funds own 97.71% of the company's stock.

Pediatrix Medical Group Trading Up 0.9%

Shares of Pediatrix Medical Group stock traded up $0.12 on Tuesday, hitting $12.76. The stock had a trading volume of 607,206 shares, compared to its average volume of 720,419. The company has a quick ratio of 1.81, a current ratio of 1.81 and a debt-to-equity ratio of 0.75. The stock's 50-day simple moving average is $13.83 and its two-hundred day simple moving average is $13.87. The stock has a market cap of $1.10 billion, a price-to-earnings ratio of -12.63, a PEG ratio of 0.85 and a beta of 1.25. Pediatrix Medical Group, Inc. has a one year low of $7.47 and a one year high of $17.67.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its quarterly earnings results on Tuesday, May 6th. The company reported $0.33 earnings per share for the quarter, beating the consensus estimate of $0.25 by $0.08. The firm had revenue of $458.36 million during the quarter, compared to the consensus estimate of $451.44 million. Pediatrix Medical Group had a positive return on equity of 17.43% and a negative net margin of 4.17%. During the same period last year, the company earned $0.20 earnings per share. The company's revenue was down 7.4% on a year-over-year basis. As a group, sell-side analysts predict that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Analyst Ratings Changes

Several research firms have recently issued reports on MD. Truist Financial reduced their target price on Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating on the stock in a report on Friday, April 11th. UBS Group lowered their target price on Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating for the company in a report on Monday, May 12th. Finally, Macquarie boosted their price target on Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an "outperform" rating in a report on Thursday, May 8th. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $16.67.

Get Our Latest Report on MD

Pediatrix Medical Group Company Profile

(Free Report)

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

Further Reading

Institutional Ownership by Quarter for Pediatrix Medical Group (NYSE:MD)

Should You Invest $1,000 in Pediatrix Medical Group Right Now?

Before you consider Pediatrix Medical Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pediatrix Medical Group wasn't on the list.

While Pediatrix Medical Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Growth Stocks That Could Pop Before Summer Ends
3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines